Tumor Biology

, Volume 36, Issue 9, pp 7085–7091 | Cite as

A Aconitum coreanum polysaccharide fraction induces apoptosis of hepatocellular carcinoma (HCC) cells via pituitary tumor transforming gene 1 (PTTG1)-mediated suppression of the P13K/Akt and activation of p38 MAPK signaling pathway and displays antitumor activity in vivo

  • Ming Liang
  • Jianchao Liu
  • Hongyu Ji
  • Moyang Chen
  • Yonghua Zhao
  • Shuchen Li
  • Xiaoyu Zhang
  • Jingyuan Li
Research Article


In this study, we observed that a Aconitum coreanum polysaccharide (CACP) exhibited an effective inhibitory effect on H22 cell growth in vitro and in vivo via the induction of apoptosis. Further, quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting assays revealed that the expression of pituitary tumor transforming gene 1 (PTTG1), one proto-oncogene, was evidently suppressed in both transcript and protein levels in H22 cell model or mice after CACP treatment. Particularly, CACP (40 μg/ml) treatment or transfection with PTTG1 small interfering RNA (siRNA) could greatly reduce the phosphorylation of Akt (p-Akt) but increase phospho-p38 mitogen-activated protein kinase (p-p38 MARK) protein levels in H22 cells as compared with vehicle-treated cells. Likewise, following treatment of H22-tumor-bearing mice with CACP (100 mg/kg), doxorubicin (DOX, 3 mg/kg), and their combination, tumor tissues showed an attenuated p-Akt protein expression, but a striking p-p38 MARK level when compared with those in model mice. Taken together, we demonstrated here the inhibitory effect of CACP on the growth of H22 cells in vitro and in vivo, which may be through, at least partly, repression of PTTG1 and then followed by the inactivation of P13/Akt and activation of p38 MARK signaling pathways. These findings offered a novel approach for the treatment of hepatocellular carcinoma (HCC) in the future.


Aconitum coreanum Polysaccharides Antitumor Pituitary tumor transforming gene 1 (PTTG1) P13K/Akt p38 MAPK 



This research was financed by the National Natural Science Foundation of China (No. 81303265).

Conflicts of interest



  1. 1.
    Qin H, Du X, Zhang Y, Wang R. Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, induces G2/M arrest and apoptosis in human hepatoma HepG2 cells by modulating the PI3K/Akt pathway. Tumour Biol. 2014;35:1267–74.CrossRefPubMedGoogle Scholar
  2. 2.
    Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.CrossRefPubMedGoogle Scholar
  3. 3.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  4. 4.
    Yang B, Xiao B, Sun T. Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice. Int J Biol Macromol. 2013;62:287–90.CrossRefPubMedGoogle Scholar
  5. 5.
    Gao J, Luo SM, Peng ML, Deng T. Enhanced immunity against hepatoma induced by dendritic cells pulsed with Hsp70-H22 peptide complexes and CD40L. J Cancer Res Clin Oncol. 2012;138:917–26.CrossRefPubMedGoogle Scholar
  6. 6.
    Koehn BH, Schoenberger SP. Tumor immunotherapy: making an immortal army. Nat Med. 2009;15:731–2.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Fridlender ZG, Buchlis G, Kapoor V, Cheng G, Sun J, Singhal S, et al. CCL2 blockade augments cancer immunotherapy. Cancer Res. 2010;70:109–18.CrossRefPubMedGoogle Scholar
  8. 8.
    Wang X1, Chen Y, Wang J, Liu Z, Zhao S. Antitumor activity of a sulfated polysaccharide from Enteromorpha intestinalis targeted against hepatoma through mitochondrial pathway. Tumour Biol. 2014;35:1641-7.Google Scholar
  9. 9.
    Drake CG, Antonarakis ES. Update: immunological strategies for prostate cancer. Curr Urol Rep. 2010;11:202–7.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kellof GJ. Perspective on cancer chemoprevention research and drug development. Adv Cancer Res. 2000;78:199–334.CrossRefGoogle Scholar
  11. 11.
    Xin T, Zhang F, Jiang Q, Chen C, Huang D, Li Y, et al. Extraction, purification and antitumor activity of a water-soluble polysaccharide from the roots of Polygala tenuifolia. Carbohydr Polym. 2012;90:1127–31.CrossRefPubMedGoogle Scholar
  12. 12.
    Vickers A. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest. 2002;20:1069–79.CrossRefPubMedGoogle Scholar
  13. 13.
    Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, et al. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends. 2010;4:297–307.PubMedGoogle Scholar
  14. 14.
    Liang M, Li SC, Shen B, Cai JP, Li C, Wang ZY, et al. Anti-hepatocarcinoma effects of Aconitum coreanum polysaccharides. Carbohydr Polym. 2012;88:973–6.CrossRefGoogle Scholar
  15. 15.
    Liang M, Chen X, Liu W, Li S, Li C, Jiang L, et al. Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma. Cancer Biol Ther. 2011;11:337–45.CrossRefPubMedGoogle Scholar
  16. 16.
    Shu D, Qing Y, Tong Q, He Y, Xing Z, Zhao Y, et al. Deltonin isolated from Dioscorea zingiberensis inhibits cancer cell growth through inducing mitochondrial apoptosis and suppressing Akt and mitogen activated protein kinase signals. Biol Pharm Bull. 2011;34:1231–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Cho-Rok J, Yoo J, Jang YJ, Kim S, Chu IS, Yeom YI, et al. Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo. Hepatology. 2006;43:1042–52.CrossRefPubMedGoogle Scholar
  19. 19.
    Fujii T, Nomoto S, Koshikawa K, Yatabe Y, Teshigawara O, Mori T, et al. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Hepatology. 2006;43:1267–75.CrossRefPubMedGoogle Scholar
  20. 20.
    Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997;9:180–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Oh JH, Lee TJ, Kim SH, Choi YH, Lee SH, Lee JM, et al. Induction of apoptosis by withaferin A in human leukemia U937 cells through downregulation of Akt phosphorylation. Apoptosis. 2008;13:1494–504.CrossRefPubMedGoogle Scholar
  22. 22.
    Srinivasan S1, Koduru S, Kumar R, Venguswamy G, Kyprianou N, Damodaran C. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells. Int J Cancer. 2009;125:961-7.Google Scholar
  23. 23.
    Genkai N, Homma J, Sano M, Tanaka R, Yamanaka R. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients. Oncol Rep. 2006;15:1569–74.PubMedGoogle Scholar
  24. 24.
    Rehfeld N, Geddert H, Atamna A, Rohrbeck A, Garcia G, Kliszewski S, et al. The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer. J Carcinog. 2006;5:4.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Ming Liang
    • 1
  • Jianchao Liu
    • 1
  • Hongyu Ji
    • 1
  • Moyang Chen
    • 1
  • Yonghua Zhao
    • 1
  • Shuchen Li
    • 1
  • Xiaoyu Zhang
    • 1
  • Jingyuan Li
    • 1
  1. 1.Department of Infectious DiseasesThe Second Affiliated Hospital of Harbin Medical UniversityHarbinChina

Personalised recommendations